Alimera Sciences

American biopharmaceutical sales company
Organization Business Q4726659
Alimera Sciences
Thomson200 · Public Domain · Wikimedia

Facts

11 properties

Identity

Legal form
8888[10]as of 2026-09-24may be stale
where from?
Edition
20260924-full · as of 2026-09-24 · newer edition 20261120 landed
Bronze
d1b68a0396f7f150 20260924-0000-gleif-goldencopy-lei2-golden-copy.csv.zip +2 files
Transform
4ort-mint · gleif · version not recorded
⚖ sources disagree Wikidata 8888 sec_form_d Delaware corporation edition 2026-10-01 · us-pd-17usc105

Status and dates

Inception
2003[7]

Location

Headquarters location
Alpharetta[4]
Located in the administrative territorial entity
Alpharetta[1]as of 2026-10-21
where from?
Edition
20261021 · as of 2026-10-21 · newer edition 20261120 landed
Bronze
7a7bf58d5ac18436 v2.15-2026-10-20-ror-data.zip
Transform
4ort-mint · ror:20261021 · version not recorded

Industry and activity

Product or material produced
medication[9]
More facts +2
Social media followers
2,291 (2021), 2,333 (2020)[11][12]
Stock exchange
Nasdaq (2010–present)[5]
🏷️ Also known as
en Alimera Sciences
🔖 Identifiers · 11
ROR ID
00endtw77
Legal Entity Identifier
5299005C650OO6FJ1R63
GRID ID
grid.488241.3
Central Index Key
0001267602
Crunchbase organization ID
alimera-sciences
Freebase ID
/m/045p1dr
Open Funder Registry funder ID
100018446as of 2026-10-21
where from?
Edition
20261021 · as of 2026-10-21 · newer edition 20261120 landed
Bronze
7a7bf58d5ac18436 v2.15-2026-10-20-ror-data.zip
Transform
4ort-mint · ror:20261021 · version not recorded
Scilit organization ID
78295
X (Twitter) username
alimerasciences (2010–present)
📚 Sources · 3

Report an error or request removal Lineage (PROV-JSON)

📈 SEC EDGAR
Public · NYSE/NASDAQ
CIK 0001267602
View SEC filings →
⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

OpenAlex IDP10283
I4210091128 2026-09-27 OpenAlex (CC0 1.0) as of 2026-09-27
where from?
Source
OpenAlex
Edition
20260927 · as of 2026-09-27
Licence
CC0 1.0
Credit
CC0 1.0 (OpenAlex snapshot, openalex.org). Values as shipped.
Bronze
not in the catalog
Transform
4ort-mint · lake · version not recorded
CC0 1.0 (OpenAlex snapshot, openalex.org). Values as shipped.
⚖️ Sworn Facts · SEC filings
parent organizationfiled
ANI PHARMACEUTICALS INC sec.gov ↗
Structured parse of sworn SEC fields only. Facts a model extracted from 8-K narrative text are not shown here — how we measure this.
🔗 Connections
Instance of 2
Country 1
Headquarters location 1
Industry 1
Product or material produced 1
Stock exchange 1
← Affiliated with 1
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 12 annual filings
Revenue
$80.75M
▲ 49.2% YoY FY2023
Net Income
-$20.13M
▼ 11.2% YoY FY2023
Assets
$153.52M
▲ 260.4% YoY FY2023
EPS (diluted)
$-0.84
▲ 67.6% YoY FY2023
$0.00$22.21M$44.41M$66.62M$88.83M FY2012: $0.00 · NI -$19.75M (0.0% margin)FY2013: $1.87M · NI -$46.23M (-2469.5% margin)FY2014: $8.42M · NI -$35.91M (-426.3% margin)FY2015: $22.44M · NI -$30.64M (-136.6% margin)FY2016: $34.33M · NI -$33.17M (-96.6% margin)FY2017: $35.91M · NI -$22.00M (-61.3% margin)FY2018: $46.60M · NI -$16.38M (-35.2% margin)FY2019: $53.94M · NI -$10.44M (-19.4% margin)FY2020: $50.82M · NI -$5.34M (-10.5% margin)FY2021: $59.03M · NI -$4.37M (-7.4% margin)FY2022: $54.13M · NI -$18.11M (-33.5% margin)FY2023: $80.75M · NI -$20.13M (-24.9% margin) '12'13'14'15'16'17'18'19'20'21'22'23
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2023-12-31 · accession 0001267602-24-000019

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Alimera Sciences. Retrieved November 19, 2026, from https://4ort.xyz/entity/alimera-sciences
MLA “Alimera Sciences.” 4ort.xyz Knowledge Graph, 4ort.xyz, 19 Nov. 2026, https://4ort.xyz/entity/alimera-sciences.
BibTeX @misc{4ortxyz_alimera-sciences_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Alimera Sciences}}, year = {2026}, url = {https://4ort.xyz/entity/alimera-sciences}, note = {Accessed: 2026-11-19}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Alimera Sciences — https://4ort.xyz/entity/alimera-sciences (retrieved 2026-11-19)

Canonical URL: https://4ort.xyz/entity/alimera-sciences · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 12w ago · Trivialist · 2026-08-22 view diff on Wikidata ↗
    HAND ID → 34E8-3884-5C61-3CD6-A985
    Social media followers → 2,291, 2,333
    Official website → http://www.alimerasciences.com/
    Instance of → business, public company
    + 16 other properties edited (see Wikidata diff for full list)
    "Created claim: HAND ID: 34E8-3884-5C61-3CD6-A985, batch #269299"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.